Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-18

Clinical Trial Update: Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating nighttime agitation and restless legs syndrome in people with Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas at Austin | Conditions: Alzheimer Disease | Phase 4 | Status: RECRUITING